Oslo, Norway, 23 January 2017: Photocure ASA announces
today that Chairperson of the Board of Directors,
Bente-Lill Romøren, has informed the Nomination
Committee that due to other assignments she will not
be a candidate for re-election when her tenure expires
at the 2017 Annual General Meeting.
For further information, please contact:
Photocure
President & CEO Kjetil Hestdal
Tel: + 47 913 19 535
Email: kh@photocure.no
Notes to editors
About Photocure ASA
Photocure, headquartered in Oslo Norway, is a
specialty pharmaceutical company and world leader in
photodynamic technology. Based on our unique
proprietary Photocure Technology(TM) platform,
Photocure develops and commercializes highly selective
and effective solutions within disease areas with high
unmet medical need, such as bladder cancer, HPV and
precancerous cervical lesions, colorectal cancer and
skin conditions. Our aim is to provide solutions which
can improve health outcomes for patients worldwide.
Photocure is listed on the Oslo Stock Exchange (OSE:
PHO). Information about Photocure is available at
www.photocure.com